Objective. Dermal inflammation from many causes may produce a reversible period of hyperalgesia (increased sensitivity to pain perception) or allodynia (pain from innocuous stimuli). Hyperalgesia and allodynia have received relatively little attention in clinical trials of acute pain. We sought to quantitate tactile allodynia and thermal hyperalgesia in outpatients presenting with acute dermal injuries.
Introduction
O ur understanding of the basic mechanisms of the perception of pain has benefited dramatically from recent progress in the neurosciences. Elucidation of pain as an integrated interaction among peripheral tissues, afferent neurons, spinal cord plasticity, higher centers, mood, and cognition has introduced a period where new findings in the basic sciences are making the transition into clinical research and therapeutics. One particularly interesting area of basic research in pain is the study of hyperalgesia and its relationship to the pain of burns and other dermal injuries. Hyperalgesia, the phenomenon of a burn becoming increasingly painful to touch, dress, or manipulations over time, is a unique feature of burns. Patient surveys have consistently demonstrated that dressing changes for severe burns represent one of the worst pains encountered in medical practice [1] . One aspect of this unfortunate condition is that dressing changes become more painful, rather than less painful, as treatment progresses.
Minor burns, abrasions, and superficial skin inflammations from irritant, infective, or allergic causes (rashes) are among the most common of painful afflictions and yet, because of their usually benign prognosis and minor nature, are rarely the subject of study in analgesia. This is unfortunate, since the mechanisms of ordinary, reversible hyperalgesia may hold clues to the intractable unsolved clinical problems of persistent hyperalgesia, allodynia, reflex dystrophy, and neuropathic pain. It should also be recognized that with allodynia (pain as a result of stimuli that do not normally evoke pain) the stimulus and response are in different modes, whereas with hyperalgesia they are in the same mode. Current evidence suggests that hyperalgesia is a consequence of perturbations of the nociceptive sensory system with peripheral or central sensitization, or both [2] .
The phenomenon of transient cutaneous hyperalgesia resulting from dermal insult or injury is well recognized in the medical literature [3, 4] and has been demonstrated following inflammation of the skin from infectious, inflammatory, allergic, thermal, and radiant (visible, infrared, or ultraviolet) injuries. Recent work in this area has examined thermal injury as an easily studied model, and experimental studies of burns in humans have shown that there is a distinct, reversible, clinical hyperalgesia that follows experimental thermal injury [5, 6] .
There is little dispute as to the occurrence of hyperalgesia, and it is reliably demonstrated that it is considered a physiological rather than a pathological response to injury and inflammation. Hyperalgesia and allodynia may be considered physiological or pathological responses depending on their chronicity and the presence or absence of an underlying cause. These responses are considered irregular, especially when associated with nerve injury and its sequel, neuropathic pain syndrome. Other disease states, such as herpetic infections, diabetic neuropathy, tumor infiltration of nerves, and neuronal degenerative states caused by systemic infection (e.g., AIDS), may present with cutaneous hyperalgesia and allodynia. Tactile allodynia and thermal hyperalgesia have distinct mechanisms but usually coexist as behavioral manifestations of neuropathic or inflammatory pain. These mechanisms are subject to intense investigations mainly due to the ineffectiveness of their management by existing pharmacological therapies. Thermal hyperalgesia may be partially due to activation of afferent C fibers, leading to elevated dynorphin levels in the spinal cord and consequent spinal sensitization via actions upon N-methyl-D-aspartate (NMDA) receptor systems. Thermal hyperalgesia, but not tactile allodynia, is blocked by spinal antisense RNA to dynorphin or by spinal NMDA antagonists but not by opioids. Tactile allodynia is mediated via large-diameter A-b afferent fibers to spinal and supraspinal loci at the brainstem. Local anesthetics injected into the gracile nucleus block tactile allodynia but not thermal hyperalgesia [7] [8] [9] [10] [11] [12] [13] .
The complex etiology of these commonly coexisting behavioral responses of neuropathic pain and of any clinical pain in general requires mechanistically designed therapeutic interventions and appropriate means for evaluation of these interventions. Evaluation of effective treatments of thermal hyperalgesia and tactile allodynia relies on sensitive and reproducible means of outcomes assessment. We sought to evaluate a set of rugged, inexpensive but sophisticated technologies of sensory testing using a randomized controlled design to quantitate subjective responses resulting from hyperalgesia and allodynia in an emergency ward population with a broad range of minor outpatient dermal insults.
Methods
This study was approved by the Institutional Review Board of the Tufts-New England Medical Center. Patients with mild dermal injuries were screened for inclusion. Patients were eligible if Hyperalgesia Assessment After Dermal Injurythey had a painful acute inflammatory dermal condition, such as actinic, thermal, chemical, mechanical, surgical, radiation, or infectious skin injury. Patients were excluded if they had current sensory impairment due to central or peripheral nerve injury, spinal cord lesion, polyneuropathy or other primary neurologic disorder, confusion or altered mental status, obtundation due to strong analgesics, or lack of suitability in the opinion of the attending physician or principal investigator due to inability or unwillingness to comply with study procedures.
Following explanation of the study to eligible patients and written informed consent, a medical history was taken and a focused physical examination of the injury was performed. Three anatomical sites were selected for testing: 1) The injured site; 2) A mirror-image contralateral site; and 3) A control site on the same side of the body as the injury in a similar anatomical location. Participants were then shown the testing equipment and allowed to familiarize themselves with this equipment.
Participants were asked to reply to three questions using a 100-mm visual analog scale (VAS) anchored at the ends (from no pain at all to the worst pain possible). The questions were:
1. How much pain do you have right now? 2. How much pain do you have if anything touches, rubs, or bumps your injured skin? 3. How much does exposure to heat or cold (like in a shower) hurt your injured skin?
Following completion of the above questionnaire and recording of the corresponding VAS scores, participants were tested at all three sites using a Medoc sensory analyzer (Medoc Ltd. Advanced Medical Systems US; Minneapolis, MN). Briefly, thermal somatosensory testing was used to measure thresholds for warmth. A small metal cube containing a thermode was applied to the three sites on the patient's skin. The device is capable of heating or cooling the skin, as needed. An adaptation temperature between 30°C and 32°C was initially determined (after a few seconds of contact with these temperatures, the participant feels neither warmth nor cold). For threshold measurement, a quantified measurable temperature stimulus is induced by the device. A simple push-button response by the patient, recorded by the computer, completes each cycle of the examination. The device was set for threshold testing of thermal pain discomfort using a train of three thermal stimuli at each site with a baseline temperature of 35°C and a 1.5°C per second ramp rate for the testing temperature. The mean score of all three stimuli on a 0-100-mm VAS was recorded as the outcome variable.
Following the Medoc testing, a series of fixed temperature challenges was performed at 40°C, 43°C, 46°C, and 49°C, and responses by the participants were recorded using a 150-mm anchored VAS scale (from no pain at all to the worst pain possible). Patients had copper test rods (Clintherm; Adolor Corporation; Malvern, PA) applied for 5 seconds in a modified random order of presentation. The random order of presentation was such that, if a mass at a given temperature caused significant discomfort (>125 mm on a 150-mm scale), a higher temperature was not used at that site to avoid further discomfort.
A coarse-faced (5-10 lines per inch each direction) 1.25-inch diameter pressure gauge was applied three times to the skin with progressively increasing pressure. In each case, we recorded the gauge reading in pounds at which the application became uncomfortable. This device was chosen instead of the more conventional Semmes-Weiss or Von Frey filaments because it produced a larger area of stimulation and reproduced a coarse touch or accidental bump.
Following sensory testing, participants were asked about the tolerability of the testing, and whether they had any suggestions for evocative tests that would better quantitate their discomfort.
Patient Population
The patient population studied consisted of 41 individuals, 18 male and 23 female, with ages ranging from 19-80 years. They presented with conditions ranging from abrasions and infected abrasions (14 patients), small area thermal burns (one first degree, eight second degree, one small third degree), rashes (four patients, probable diagnoses: irritant and heat rash), and sunburn (two patients), to less common conditions such as poison ivy (two patients), trophic ulcers (two patients), and neuropathic pain (two patients), and single cases of cellulitis, laceration, scleroderma with cellulitis, shingles, and crush injury.
Most of the patients studied were self-referred and had patterns of injury consistent with primary care or emergency room presentations. The majority of conditions were injuries of an upper extremity (22) or lower extremity (13) , with a few facial (2), neck (1), and truncal sites (3). The majority of patients had used no analgesic (25) or, at most, acetaminophen, aspirin, or over-thecounter nonsteroidal anti-inflammatory drugs (14) . Only one patient had been taking an opioidcontaining combination medication.
Protocol Adherence
Two patients were enrolled who might not have met the original admission criteria, having a diagnosed neuropathy. One had clear sensory hypoesthesia and was excluded; the other did not and was retained. The rest of the patients completed the study with complete data collection, though heat pain threshold data were lost for one patient (PS, abrasion) due to equipment failure, and pressure threshold data were not collected on a second patient (CRK, facial burn) in whom pressure testing might have caused a worsening of the injury due to location.
Statistical Analysis
Statistical analyses for comparisons between groups or subgroups of VAS were performed using one-way analysis of variance (ANOVA) followed by post-hoc tests: Student-Newman-Keuls, for multiple comparison procedures, or Dunn's test, for comparisons with control groups. When the normality test failed, the Kruskal-Wallis one-way ANOVA on ranks was used. The power of performed tests with a = 0.05 was >0.9. All data in tables and figures are presented as the mean ± standard error of the mean (SEM).
Results
The distributions of VAS pain scores prior to sensory testing in the group as a whole and in subgroups of patients according to type of injury are shown in Table 1 . A significant increase in pain intensity was observed after light touch or application of hot or cold during Medoc testing at the site of injury, compared with pain intensity at rest (P < 0.05). In a subgroup analysis, significantly greater pain intensities were observed after light touch, compared with pain at rest, only in those patients with abrasions, suggesting that, in this type of injury, tactile allodynia may occur without thermal hyperalgesia. Differences between pain at rest and pain after touch or application of hot or cold were not significant in any other subgroup, although trends toward increased pain scores were observed in all subgroups.
The distributions of scores for the group as a whole and for the diagnostic subgroups for thermal discomfort threshold testing with the Medoc device are presented in Table 2 .
The Clintherm challenge resulted in a set of VAS scores for each patient for intact skin in a control area, for intact skin in a mirror-image area, and for the injured area at each temperature. Table 3 and Figure 1 show these mean scores for the group as a whole at each temperature and site tested (each value in the table is the mean of two measurements). The mean VAS scores for all four Clintherm test temperatures by diagnostic group are presented in Table 4 . Table 5 gives the results of the pressure threshold testing by group, using the mean values for three tests per condition per patient. Thermal discomfort thresholds across sites differed significantly (P < 0.001 by Kruskal Wallis one-way ANOVA on ranks). * P < 0.05, in comparison with the control site, by Dunn's post-hoc test. VAS scores after thermal challenge at different sites differed significantly (P < 0.001 by one-way ANOVA). * P < 0.05 versus control site or † P < 0.05 versus control site, by Dunn's post-hoc test for group comparisons.
Overall, the two approaches to thermal sensory testing-one relying upon a more sophisticated, fragile, and expensive apparatus, the other using a simpler, more rugged, and inexpensive deviceproduced equally robust measures of allodynia and hyperalgesia. Another simple, sturdy, and low-cost instrument provided clear evidence of tactile hyperalgesia. All participants were specifically asked if they had any difficulty with the testing or if it was objectionable to them. All responded that the testing was tolerable, though five participants recommended that there be some modification of the pressure gauge testing to make it less irritating to the skin.
Discussion
The observations from this study showed a remarkably consistent pattern of responses across patients, subgroups, and testing methods. All patients with dermal injuries, regardless of cause, reported that they had greater discomfort when their injury was subjected to light mechanical stimulation (touch), heat, or cold. Objective testing of thermal discomfort thresholds (Medoc), subjective discomfort testing using thermal challenge with ordinarily nonpainful stimuli (Clintherm), and tactile testing with a normally nonpainful stimulus (pressure gauge) all produced evidence of significant tactile allodynia and thermal hyperalgesia. Thermal hyperalgesia presented as a leftward shift of the thermal stimulus-response curve, such that otherwise nonpainful stimuli (e.g., the thermal mass at the site of injury at 43°C) became painful. The magnitude of the thermal hyperalgesia appeared to be nonspecific for the condition that caused it. However, there may be a correlation between the degree and the intensity or duration of inflammation that could not be detected in this preliminary study. We conclude that thermal hyperalgesia, defined as an increased nociceptive response to a thermal stimulus, is a common, reversible correlate of dermal injury. Thermal hyperalgesia and tactile allodynia are perceived by patients as distinct sensory dimensions of pain and can be easily and consistently evaluated in the clinical setting by both objective and subjective means. Furthermore, these types of pain are legitimate targets of novel therapeutic interventions, since they are generated by distinct mechanisms. The techniques of assessment of thermal hyperalgesia and tactile allodynia evaluated in the present study offer simple and accurate means for the evaluation and management of painful dermal conditions. A recent workshop on analgesic drug development by experts at the U.S. Food and Drug Administra- VAS scores after pressure threshold testing at different sites differed significantly (P < 0.001 by one-way ANOVA on ranks). * P < 0.05 versus control site or † P < 0.05 versus mirror site, by Dunn's posthoc test.
tion pointed out that the antihyperalgesic effects of novel drugs may not be identified if their activity is evaluated only for spontaneous pain [14] . The techniques assessed in our study may prove useful in evaluating these effects. In addition, all participants in our study were asked if there were any other methods of elicitation of hyperalgesia appropriate to their situation. Six patients had suggestions that included: range of motion elicitation of hyperalgesia (one), application of alcohol to cool the skin (one), cold stimuli (two), and a brush test (two). Progress in our understanding of the pathophysiology of the transition from acute to chronic pain and the impact that different clinical presentations may have upon this transition suggests that analysis of such presentations by the simple means we have applied may advance our assessment and understanding of post-injury pain [15] .
